✦ LIBER ✦

Intrathoracic hypotonic CDDP treatment (HPT) for malignant pleural effusion in patients with non-small cell lung cancer (NSCLC). A phase II study

✍ Scribed by Ichinose, Y; Seto, T; Senba, H; Yamamoto, H; Ushijima, S; Araki, J; Inoue, Y; Itoh, K; Tamanoi, M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-677 Intrapleural hypotonic cisplatin t

✍ Ebi, Noriyuki; Seto, Takashi; Yamamoto, Hidehiko; Ito, Kazunobu; Araki, Jun; Ush 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Phase II trial of intrapleural paclitaxe

✍ R.-P. Perng; Y.-M. Chen; M.-F. Wu; K.-C. Chou; W.-C. Lin; J.M. Liu; J. Whang-Pen 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 764 KB

A phase II trial of oral UFT plus cispla

✍ Saito, Junichi; Nakai, Yushi; Saijo, Yasuo; Nukiwa, Toshihiro; Koinumaru, Sadahi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 87 KB

A phase II study of UFT plus cisplatin (

✍ Nakanishi, Y; Fujita, M; Ninomiya, K; Motohiro, A; Kanegae, H; Osaki, S; Watanab 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 234 KB

A phase I clinical and pharmacokinetic s

✍ Xianhuo Wang; Junchao Zhou; Yongsheng Wang; Zhengyan Zhu; You Lu; Yuqan Wei; Lij 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 173 KB

148 A phase II trial of oral UFT plus ci

✍ Saito, J.; Nakai, Y.; Koinumaru, S. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 157 KB